Heidenreich W, Jagla K, Schüssler J, Börner P, Dehnhard F, Deinhardt J, Kalden J, Peter H H, Deicher H
J Cancer Res Clin Oncol. 1979 Sep;95(1):65-74. doi: 10.1007/BF00411111.
Mononuclear cells from peripheral blood and draining lymph nodes of 40 patients with invasive mammary carcinoma were examined for various immunological cell surface markers including surface membrane immunoglobulins and rosetting properties (E, EA, EAC). No significant relationship could be established to anyone of the following criteria for which the literature reports varying prognostic values: Clinical staging of the disease , histological tumor type, grading, nuclear differentiation, round cell infiltration, perivenous infiltration, sinus histiocytosis, and lymph node reaction patterns (lymphocyte predominance, germinal center predominance, lymphocyte depletion, unstimulated nodes). From the reported results it is concluded that the analysis of lymphocyte cell surface markers in mammary carcinoma is not a suitable parameter for supporting the existence of specific or unspecific anti-tumor immune reactions which may be suspected from certain histological reaction patterns.
对40例浸润性乳腺癌患者外周血及引流淋巴结中的单核细胞进行了检查,检测了包括表面膜免疫球蛋白和玫瑰花结形成特性(E、EA、EAC)在内的多种免疫细胞表面标志物。对于文献报道具有不同预后价值的以下任何一项标准,均未发现显著相关性:疾病的临床分期、组织学肿瘤类型、分级、核分化、圆形细胞浸润、静脉周围浸润、窦组织细胞增生以及淋巴结反应模式(淋巴细胞为主、生发中心为主、淋巴细胞耗竭、未受刺激的淋巴结)。根据报告结果得出结论,乳腺癌中淋巴细胞细胞表面标志物的分析并非一个合适的参数,无法支持从某些组织学反应模式推测出的特异性或非特异性抗肿瘤免疫反应的存在。